International Patent: SUSTAINED RELEASE LIPOSOMAL PHARMACEUTICAL EMBOLIZING AGENTS FOR TREATING CHRONIC SUBDURAL HEMATOMA, INTRACTABLE MIGRAINES, HEADACHES, AND OTHER PAIN CONDITIONS

GENEVA, Oct. 1 -- MG STROKE ANALYTICS INC. filed a patent application (CA2026/050392) for “SUSTAINED RELEASE LIPOSOMAL PHARMACEUTICAL EMBOLIZING AGENTS FOR TREATING CHRONIC SUBDURAL HEMATOMA, INTRACTABLE MIGRAINES, HEADACHES, AND OTHER PAIN CONDITIONS”. With publication no. WO/2026/188338, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61B 17/12

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....